Journal of Diabetes and Its Complications
Volume 19, Issue 3 , Pages 147-154 , May 2005

Levels of plasma total adrenomedullin are related with two acute phase inflammatory reactants (fibrinogen and sialic acid) but not with markers of endothelial dysfunction in Type 1 diabetes: Adrenomedullin and vascular risk factors in Type 1 DM

  • M.T. García-Unzueta

      Affiliations

    • Endocrinology Service, Endocrine Unit, Hospital Universitario M. de Valdecilla, Valdecilla Street, Santander 39008, Spain
    • ,
  • J.R. Berrazueta

      Affiliations

    • Cardiology Service, Hospital Universitario M. de Valdecilla, University of Cantabria, Valdecilla Street, Santander 39008, Spain
    • ,
  • C. Pesquera

      Affiliations

    • Endocrinology Service, Endocrine Unit, Hospital Universitario M. de Valdecilla, Valdecilla Street, Santander 39008, Spain
    • ,
  • S. Obaya

      Affiliations

    • Clinical Biochemistry Service, Hospital Universitario M. de Valdecilla, University of Cantabria, Valdecilla Street, Santander 39008, Spain
    • ,
  • M.D. Fernández

      Affiliations

    • Clinical Biochemistry Service, Hospital Universitario M. de Valdecilla, University of Cantabria, Valdecilla Street, Santander 39008, Spain
    • ,
  • C. Sedano

      Affiliations

    • Haematology Service, Hospital Universitario M. de Valdecilla, University of Cantabria, Valdecilla Street, Santander 39008, Spain
    • ,
  • J.A. Amado

      Affiliations

    • Endocrinology Service, Endocrine Unit, Hospital Universitario M. de Valdecilla, Valdecilla Street, Santander 39008, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34 942 202514; fax: +34 942 201695

Received 12 May 2004 ,Revised 26 August 2004 ,Accepted 31 August 2004.

References 

  1. Amado JA, Fidalgo I, García-Unzueta MT, Montalbán C, Del Moral I, Pazos F, et al. Patients with poor preoperative ejection fraction have a higher plasma response of adrenomedullin in response to open heart surgery. Acta Anaesthesiologica Scandinavica. 1999;43:829–833
  2. American Diabetes Association . Treatment of hypertension in diabetes. Diabetes Care. 1993;16:1394–1401
  3. Cheung B, Leung R. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clinical Science. 1997;92:59–62
  4. Cronin CC, McPartlin JM, Barry DG, Ferriss JB, Scott JM, Weir DG. Plasma homocysteine concentrations in patients with type 1 diabetes. Diabetes Care. 1998;21:1843–1847
  5. Crook M, Cartwright K, Lumb P, Worsley A. Serum sialic acid in young type-1 diabetic patients. Diabetes Research and Clinical Practice. 2000;47:119–122
  6. Crook MA, Hag M, Tutt P. Serum sialic acid and its relationship to various haematological parameters, including erythrocyte sedimentation rate. British Journal of Biomedical Science. 1997;54:100–103
  7. Ehlenz K, Koch B, Preuss P, Simon B, Koop I, Lang RE. High levels of circulating adrenomedullin in severe illness: correlation with C-reactive protein and evidence against the adrenal medulla as site of origin. Experimental and Clinical Endocrinology & Diabetes. 1997;105:156–162
  8. Elhadd TA, Kennedy G, Hill A, Mc Laren M, Newton RW, Greene SA, et al. Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical vascular disease. Diabetes Metabolism Research and Reviews. 1999;15:405–411
  9. Ernst E, Koenig W. Fibrinogen and cardiovascular risk. Vascular Medicine. 1997;2:115–125
  10. Eto T, Kitamura K, Kato J. Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases. Clinical and Experimental Pharmacology and Physiology. 1999;26:371–380
  11. Fábrega E, Casafont F, Crespo J, De la Peña J, San Miguel G, De las Heras G, et al. Plasma adrenomedullin levels in patients with hepatic cirrosis. American Journal of Gastroenterology. 1997;92:1901–1904
  12. Fasching P, Veitl M, Rohac M, Streli C, Scheneider B, Waldhäusl W, et al. Elevated concentrations of circulatin adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism. 1996;81:4313–4317
  13. García-Unzueta MT, Montalbán C, Pesquera C, Berrazueta JR, Amado JA. Plasma adrenomedullin levels in type 1 diabetes. Diabetes Care. 1998;21:999–1003
  14. Genesca J, González A, Catalan R, Segura R, Martinez M, Esteban R, et al. Adrenomedullin, a vasodilator peptide implicated in hemodynamic alterations of liver cirrhosis: relationship to nitric oxide. Digestive Diseases and Sciences. 1999;44:372–376
  15. Greaves M, Malia RG, Goodfellow K, Mattock M, Stevens LK, Stephenson JM, et al. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study. Diabetologia. 1997;40:698–705
  16. Hayashi M, Shimosawa T, Isaka M, Yamada S, Fujita R, Fujita T. Plasma adrenomedullin in diabetes. Lancet. 1997;350:1449–1450
  17. Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocrine Reviews. 2000;21:138–167
  18. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, et al. Increased circulating adrenomedullin, a novel vasodilatory peptide in sepsis. Journal of Clinical Endocrinology and Metabolism. 1996;81:1449–1453
  19. Hopfner RL, Gopalakrishnan V. Endothelin: emerging role in diabetic vascular complications. Diabetologia. 1999;42:1383–1394
  20. Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. Journal of Clinical Investigation. 1994;94:2158–2161
  21. Jougasaki M, Burnett JC. Adrenomedullin: potential in physiology and pathophysiology. Life Science. 2000;66:855–872
  22. Jougasaki M, Wei C, McKinley LJ, Burnett JC. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation. 1995;92:286–289
  23. Kinoshita H, Kato K, Kuroki M, Nakamura S, Kitamura K, Hisanaga S, et al. Plasma adrenomedullin levels in patients with diabetes. Diabetes Care. 2000;22:253–255
  24. Kirilov G, Dakovska L, Borisova AM, Krivoshiev S, Nentchev N. Increased plasma endothelin levels in patients with insulin-dependent diabetes mellitus and end-stage vascular complications. Hormone and Metabolic Research. 1994;26:119–120
  25. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochemical and Biophysical Research Communications. 1993;192:553–560
  26. Kobayashi K, Kitamura K, Etoh T, Nagatomo Y, Takenaga M, Ishikawa T, et al. Increased plasma adrenomedullin levels in chronic congestive heart failure. American Heart Journal. 1996;131:994–998
  27. Kobayashi K, Kitamura K, Hirayama N, Date H, Kashiwagi T, Ikushima I, et al. Increased plasma adrenomedullin in acute myocardial infarction. American Heart Journal. 1996;131:676–680
  28. Kohno M, Hanehira T, Kano H, Horio T, Yokokawa K, Ikeda M, et al. Plasma adrenomedullin concentrations in essential hypertension. Hypertension. 1996;27:102–107
  29. Krolewski AS, Laffel L, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. New England Journal of Medicine. 1995;332:1251–1255
  30. Kubo A, Minamino N, Isumi Y, Katafuchi T, Kangawa K, Dohi K, et al. Production of adrenomedullin in macrophage cell line and peritoneal macrophage. Journal of Biological Chemistry. 1998;273:16730–16738
  31. Lieberman J, Sastre A. Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Annals of Internal Medicine. 1980;93:825–826
  32. Malamitsi-Puchner A, Economou E, Katsouyanni K, Karachaliou F, Delis D, Bartsocas CS. Endothelin 1-21 plasma concentrations in children and adolescents with insulin dependent diabetes mellitus. Journal of Pediatric Endocrinology & Metabolism. 1996;9:463–468
  33. Myrup B, De Maat M, Rossing P, Gram J, Kulft C, Jespersen J. Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. Thrombotic Research. 1996;81:485–490
  34. Nishikimi T, Matsuoka H, Shimada K, Matsuo H, Kangawa K. Production and clearance sites of two molecular forms of adrenomedullin in human plasma. American Journal of Hypertension. 2000;13:1032–1034
  35. Olson JA, Whitelaw CM, McHardy KC, Pearson DWM, Forrester JV. Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia. 1997;40:1166–1171
  36. Powrie JK, Watts GF, Crook MA, Ingham JN, Taub NA, Shaw KM. Serum sialic acid and the long-term complications of insulin-dependent diabetes mellitus. Diabetic Medicine. 1996;13:238–242
  37. Samson WK. Adrenomedullin and the control of fluid and electrolyte homeostasis. Annual Review of Physiology. 1999;61:363–389
  38. Sarman B, Farkas K, Toth M, Somogyi A, Tulassay Z. Circulating plasma endothelin-1, plasma lipids and complications in type 1 diabetes mellitus. Diabetes, Nutrition and Metabolism. 2000;13:142–148
  39. Schell DA, Vari RC, Samson WK. Adrenomedullin: a newly discovered hormone controlling fluid and electrolyte homeostasis. Trends in Endocrinology and Metabolism. 1996;7:7–13
  40. Stehouwer CDA, Andreas Fischer HR, Arno WR, van Kuijk AWR, Polak BCP, Donher AbJM. Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes. 1995;44:561–564
  41. Sugo S, Minamino M, Shoji H, Kangawa K, Kitamura K, Eto T, et al. Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochemical and Biophysical Research Communications. 1995;207:25–32
  42. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochemical and Biophysical Research Communications. 1994;201:1160–1166
  43. Turk HM, Buyukberber S, Sevinc A, Ak G, Ates N, Sari R, et al. Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes. Diabetes Care. 2000;23:864–867
  44. Ustundag B, Canatan H, Cinkilinc N, Halifeoglu I, Bahcecioglu IH. Angiotensin converting enzyme (ACE) activity levels in insulin-dependent diabetes mellitus and effect of ACE levels on diabetic patients with nephropathy. Cell Biochemistry and Function. 2000;18:23–28

PII: S1056-8727(04)00094-7

doi: 10.1016/j.jdiacomp.2004.08.002

Journal of Diabetes and Its Complications
Volume 19, Issue 3 , Pages 147-154 , May 2005

Article Tools